Drug intelligence / Profile preview

C-dot nanozyme

Development stage
Preclinical
Modality
Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Intratumoral, Topical, Intranasal
01

Overview

C-dot nanozymes are nanomaterials composed of carbon dots (CDs) that exhibit intrinsic enzyme-like catalytic activities. These quantum-sized nanoparticles can mimic natural enzymes such as superoxide dismutase (SOD), peroxidase, and oxidase. Their mechanism of action involves catalyzing redox reactions—such as the conversion of superoxide anions and hydrogen peroxide—leading to the regulation of reactive oxygen species (ROS) within biological systems. This property enables them to disturb oxidative homeostasis in tumor cells or protect neurons from oxidative stress. C-dot nanozymes have been engineered for various biomedical applications: - As drug carriers for co-delivery systems combining chemotherapeutics (e.g., doxorubicin) and siRNA to overcome drug resistance in cancers by suppressing targets like MRP1 and oxidizing glutathione[1]. - As antibacterial agents through peroxidase-mimetic activity that generates ROS toxic to bacteria[2]. - As neuroprotective agents by scavenging ROS in neurological diseases such as ischemic stroke or Alzheimer's disease[3]. Surface modifications—including doping with metals or functionalization with aptamers—can further enhance their catalytic efficiency and targeting capabilities[4]. They are noted for high biocompatibility, low cytotoxicity, stable chemical inertness, water dispersibility, and tunable surface chemistry.

Other names
carbon dot nanozymeCD-based nanozymeCDs-based nanozymecarbon dots (CDs) with enzyme-like activity

Beyond the preview

Go deeper on C-dot nanozyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-dot nanozyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call